26 Jan Guideline For Electronic Submission of Clinical Trial Documents (Amendments, Bioequivalence Studies, Responses, Notifications, And Serious Adverse Events)
Posted at 14:02h
in
This guideline serves as a guide to applicants on the electronic submission process for major activities performed within Clinical Trials Unit (CTU).
Archives
Download Version 2 (9.59)Date updated
2022 Sept
Download
File Type:
pdf
Category:
Communication to industry, Guideline